Genome engineering using the CRISPR-Cas9 system
Top Cited Papers
- 24 October 2013
- journal article
- research article
- Published by Springer Nature in Nature Protocols
- Vol. 8 (11) , 2281-2308
Abstract
Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1–2 weeks, and modified clonal cell lines can be derived within 2–3 weeks.Keywords
This publication has 64 references indexed in Scilit:
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryosCell Research, 2013
- A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease ModelsCell Stem Cell, 2013
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- FLASH assembly of TALENs for high-throughput genome editingNature Biotechnology, 2012
- Translocation capture sequencing: A method for high throughput mapping of chromosomal rearrangementsJournal of Immunological Methods, 2011
- Genetic engineering of human pluripotent cells using TALE nucleasesNature Biotechnology, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Efficient construction of sequence-specific TAL effectors for modulating mammalian transcriptionNature Biotechnology, 2011
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007